Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovis (ENOV) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Enovis (ENOV) over the last 17 years, with Q4 2025 value amounting to $355.2 million.

  • Enovis' Accumulated Expenses rose 87.63% to $355.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $355.2 million, marking a year-over-year increase of 87.63%. This contributed to the annual value of $329.9 million for FY2024, which is 3910.94% up from last year.
  • According to the latest figures from Q4 2025, Enovis' Accumulated Expenses is $355.2 million, which was up 87.63% from $336.1 million recorded in Q3 2025.
  • Enovis' 5-year Accumulated Expenses high stood at $490.0 million for Q2 2022, and its period low was $197.8 million during Q1 2023.
  • Moreover, its 5-year median value for Accumulated Expenses was $329.9 million (2024), whereas its average is $311.8 million.
  • In the last 5 years, Enovis' Accumulated Expenses plummeted by 5964.62% in 2023 and then soared by 8876.13% in 2024.
  • Enovis' Accumulated Expenses (Quarter) stood at $225.4 million in 2021, then decreased by 6.7% to $210.3 million in 2022, then increased by 12.76% to $237.1 million in 2023, then soared by 39.11% to $329.9 million in 2024, then rose by 7.69% to $355.2 million in 2025.
  • Its Accumulated Expenses stands at $355.2 million for Q4 2025, versus $336.1 million for Q3 2025 and $269.2 million for Q2 2025.